The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Dosing decitabine and venetoclax for terminal differentiation to improve outcomes in TP53 mutant MDS and AML.
 
Bradley Rockwell
No Relationships to Disclose
 
Ioannis Mantzaris
Honoraria - Syndax
Travel, Accommodations, Expenses - Adaptive Biotechnologies
 
Aditi Shastri
Honoraria - Great Debates and Updates; Peerview
Consulting or Advisory Role - Kymera; Ryvu Therapeutics
Research Funding - Kymera; Ryvu Therapeutics
 
Brian Jonas
Consulting or Advisory Role - Abbvie; BMS; Gilead Sciences; Kura Oncology; Rigel; Schrodinger; Syndax; Treadwell Therapeutics
Research Funding - Abbvie (Inst); Amgen (Inst); Aptose Biosciences (Inst); AROG (Inst); Biomea Fusion (Inst); BMS (Inst); Celgene (Inst); FORMA Therapeutics (Inst); Forty Seven (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Glycomimetics (Inst); Hanmi (Inst); Immune-Onc Therapeutics (Inst); Jazz Pharmaceuticals (Inst); Kymera (Inst); Loxo (Inst); Pfizer (Inst); Pharmacyclics (Inst); Treadwell Therapeutics (Inst)
Travel, Accommodations, Expenses - Rigel
Other Relationship - Gilead Sciences
 
Yogen Saunthararajah
Stock and Other Ownership Interests - EpiDestiny; Treebough Therapies
Patents, Royalties, Other Intellectual Property - US-11376270-B2; US-9259469-B2; US-9265785-B2; US-9895391-B2; US-9926316-B2
 
David Levitz
No Relationships to Disclose
 
Jhannine Verceles
No Relationships to Disclose
 
Dennis Cooper
No Relationships to Disclose
 
Anne Munoz
No Relationships to Disclose
 
Aradhika Dhawan
No Relationships to Disclose
 
Kith Pradhan
No Relationships to Disclose
 
Noah Kornblum
No Relationships to Disclose
 
Alejandro Sica
No Relationships to Disclose
 
Stephen Peeke
No Relationships to Disclose
 
Ridhi Gupta
No Relationships to Disclose
 
Kira Gritsman
Research Funding - ADC Therapeutics; iOnctura
 
Marina Konopleva
Stock and Other Ownership Interests - Reatna Pharmaceuticals
Consulting or Advisory Role - Abbvie; AstraZeneca; Auxenion; BAKX Therapeutics; Boehringer Pharma GmbH; Dark Blue Therapeutics; Genentech; Gilead Sciences; Janssen; Legend Biotech; MEI Pharma; Redona Therapeutics; Roche; Sanofi; Sellas Life Sciences; Stemline Therapeutics; Vincerx Pharma
Research Funding - Abbvie; AstraZeneca; Genentech; Gilead Sciences; ImmunoGen; MEI Pharma; Precision Advisors; Sanofi; Stemline Therapeutics
Patents, Royalties, Other Intellectual Property - Lilly; Novartis; Reatna Pharmaceuticals
 
Eric Feldman
No Relationships to Disclose
 
Amit Verma
Stock and Other Ownership Interests - Stelexis Therapeutics; ThromboGenics
Honoraria - Janssen; Stelexis Therapeutics
Consulting or Advisory Role - Acceleron Pharma; Celgene; Novartis; Stelexis Therapeutics
Research Funding - Bristol-Myers Squibb; Curis; GlaxoSmithKline; Incyte; Lilly; MedPacto; Prelude Therapeutics
 
Mendel Goldfinger
No Relationships to Disclose